EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benchmarking Cross-Docking Strategies in Kinase Drug Discovery

David A Schaller iD, Clara D Christ iD, John D Chodera iD, Andrea Volkamer iD

Journal of Chemical Information and Modeling · 09.12.2024 · 64 (23) · 8848-8858

DOI: 10.1021/acs.jcim.4c00905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 19.11.2024. Verfasst von David A Schaller und 3 weiteren Autor:innen. Beteiligte Einrichtung: In Silico Toxicology and Structural Bioinformatics, Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universi…. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Drug Discovery, Protein Kinase Inhibitors, Protein Kinases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Bayer, Memorial Sloan-Kettering Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationDrug DiscoveryProtein Kinase InhibitorsProtein KinasesLigandsProtein ConformationMachine LearningProtein Binding

Substanzen

Protein Kinase InhibitorsLigandsProtein Kinases

Autor:innen und Institutionen

  • In Silico Toxicology and Structural Bioinformatics, Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1,…
  • Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Structural Biology & Computational Design, Drug Discovery Sciences, Pharmaceuticals, Bayer AG, 13342 Berlin, Germany.
  • Data Driven Drug Design, Faculty of Mathematics and Computer Sciences, Saarland University, 66123 Saarbrücken, Germany.

ORCID-Profile: David A Schaller, Clara D Christ, John D Chodera, Andrea Volkamer

Förderung

  • NCI NIH HHS
  • Bayer
  • Memorial Sloan-Kettering Cancer Center
  • Berlin Institute of Health
  • National Institutes of Health

Zitieren

APA

Schaller, D. A., Christ, C. D., Chodera, J. D., & Volkamer, A. (2024). Benchmarking Cross-Docking Strategies in Kinase Drug Discovery. Journal of Chemical Information and Modeling, 64(23), 8848-8858. https://doi.org/10.1021/acs.jcim.4c00905

Vancouver

Schaller DA, Christ CD, Chodera JD, Volkamer A. Benchmarking Cross-Docking Strategies in Kinase Drug Discovery. Journal of Chemical Information and Modeling. 2024;64(23):8848-8858. doi:10.1021/acs.jcim.4c00905

BibTeX
@article{Schaller2024,
  author = {Schaller, David A and Christ, Clara D and Chodera, John D and Volkamer, Andrea},
  title = {Benchmarking Cross-Docking Strategies in Kinase Drug Discovery},
  journal = {Journal of Chemical Information and Modeling},
  year = {2024},
  volume = {64},
  number = {23},
  pages = {8848--8858},
  doi = {10.1021/acs.jcim.4c00905}
}
Kostenlos starten →